SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 136 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,271,000 | -49.4% | 228,628 | +13.3% | 0.01% | -53.3% |
| Q3 2016 | $12,393,000 | +287.3% | 201,813 | +20.3% | 0.02% | +275.0% |
| Q2 2016 | $3,200,000 | +5.1% | 167,788 | +7.6% | 0.00% | 0.0% |
| Q1 2016 | $3,044,000 | -45.4% | 155,963 | +8.0% | 0.00% | -42.9% |
| Q4 2015 | $5,574,000 | -0.6% | 144,471 | -17.3% | 0.01% | -12.5% |
| Q3 2015 | $5,607,000 | +3.0% | 174,606 | -2.4% | 0.01% | +14.3% |
| Q2 2015 | $5,446,000 | +171.4% | 178,960 | +18.4% | 0.01% | +133.3% |
| Q1 2015 | $2,007,000 | +2.8% | 151,093 | +11.9% | 0.00% | 0.0% |
| Q4 2014 | $1,953,000 | -17.1% | 134,976 | +20.8% | 0.00% | 0.0% |
| Q3 2014 | $2,357,000 | -28.9% | 111,691 | +0.4% | 0.00% | -25.0% |
| Q2 2014 | $3,315,000 | +33.0% | 111,277 | +7.3% | 0.00% | 0.0% |
| Q1 2014 | $2,492,000 | +18.8% | 103,693 | +0.7% | 0.00% | +33.3% |
| Q4 2013 | $2,097,000 | -53.1% | 102,968 | +8.8% | 0.00% | -57.1% |
| Q3 2013 | $4,469,000 | +39.1% | 94,615 | +12.1% | 0.01% | +16.7% |
| Q2 2013 | $3,212,000 | – | 84,436 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |